GSA Capital Partners’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

GSA Capital Partners’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-47,416	Closed	-$233K	–	2207
2016 Q4	$233K	Buy	+47,416	New	+$243K	0.01%	1499
2016 Q2	–	Sell	-72,601	Closed	-$415K	–	2080
2016 Q1	$415K	Sell	72,601 -26,300	-27%	-$184K	0.03%	1127
2015 Q4	$1.03M	Buy	98,901 +9,702	+11%	+$132K	0.05%	688
2015 Q3	$1.65M	Buy	89,199 +18,031	+25%	+$348K	0.08%	358
2015 Q2	$1.39M	Buy	71,168 +24,141	+51%	+$427K	0.05%	633
2015 Q1	$827K	Buy	+47,027	New	+$790K	0.03%	1022
2014 Q3	–	Sell	-16,977	Closed	-$265K	–	2158
2014 Q2	$265K	Buy	+16,977	New	+$250K	0.01%	1481
2013 Q3	–	Sell	-21,457	Closed	-$216K	–	1780
2013 Q2	$216K	Buy	+21,457	New	+$225K	0.03%	1046

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

GSA Capital Partners's OSIR Position: Q1 2017 in Review

GSA Capital Partners sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 47,416 shares — an estimated $233K sold.

GSA Capital Partners first reported a position in OSIR in Q2 2013 and held it in 8 quarters. The position peaked at $1.65M in Q3 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

GSA Capital Partners reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
GSA Capital Partners sold 47,416 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $233K.
GSA Capital Partners first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
GSA Capital Partners's Osiris Therapeutics, Inc. Common Stock position peaked at $1.65M in Q3 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on GSA Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.